This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Mar;162(3):633-4; author reply 635.

doi: 10.1176/appi.ajp.162.3.633-b.

Neurotensin receptor agonists and antagonists for schizophrenia

Elliott Richelson, Paul A Fredrickson, Mona M Boules

PMID: 15741499
DOI: 10.1176/appi.ajp.162.3.633-b

Comment

Neurotensin receptor agonists and antagonists for schizophrenia

Elliott Richelson et al. Am J Psychiatry. 2005 Mar.

. 2005 Mar;162(3):633-4; author reply 635.

doi: 10.1176/appi.ajp.162.3.633-b.

Authors

Elliott Richelson, Paul A Fredrickson, Mona M Boules

PMID: 15741499
DOI: 10.1176/appi.ajp.162.3.633-b

No abstract available

PubMed Disclaimer

Comment on

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
Meltzer HY, Arvanitis L, Bauer D, Rein W; Meta-Trial Study Group. Meltzer HY, et al. Am J Psychiatry. 2004 Jun;161(6):975-84. doi: 10.1176/appi.ajp.161.6.975. Am J Psychiatry. 2004. PMID: 15169685 Clinical Trial.

Similar articles

Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats.
Keiser AA, Matazel KS, Esser MK, Feifel D, Prus AJ. Keiser AA, et al. Exp Clin Psychopharmacol. 2014 Dec;22(6):541-7. doi: 10.1037/a0037912. Epub 2014 Sep 15. Exp Clin Psychopharmacol. 2014. PMID: 25222546 Free PMC article.
Neurotensin receptor agonists and antagonists for schizophrenia.
Robertson VB, Wilson MS 2nd. Robertson VB, et al. Am J Psychiatry. 2005 Mar;162(3):634; author reply 635. doi: 10.1176/appi.ajp.162.3.634. Am J Psychiatry. 2005. PMID: 15741502 No abstract available.
Neurotensin agonists as an alternative to antipsychotics.
Boules M, Fredrickson P, Richelson E. Boules M, et al. Expert Opin Investig Drugs. 2005 Apr;14(4):359-69. doi: 10.1517/13543784.14.4.359. Expert Opin Investig Drugs. 2005. PMID: 15882113 Review.
Novel treatments of schizophrenia: targeting the neurotensin system.
Kinkead B, Nemeroff CB. Kinkead B, et al. CNS Neurol Disord Drug Targets. 2006 Apr;5(2):205-18. doi: 10.2174/187152706776359655. CNS Neurol Disord Drug Targets. 2006. PMID: 16611093 Review.
Neurotensin analogs indications for use as potential antipsychotic compounds.
McMahon BM, Boules M, Warrington L, Richelson E. McMahon BM, et al. Life Sci. 2002 Jan 25;70(10):1101-19. doi: 10.1016/s0024-3205(01)01520-x. Life Sci. 2002. PMID: 11848295 Review.

See all similar articles

Cited by

The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.
Shilling PD, Feifel D. Shilling PD, et al. Pharmacol Biochem Behav. 2008 Oct;90(4):748-52. doi: 10.1016/j.pbb.2008.05.025. Pharmacol Biochem Behav. 2008. PMID: 18577396 Free PMC article.
Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats.
Keiser AA, Matazel KS, Esser MK, Feifel D, Prus AJ. Keiser AA, et al. Exp Clin Psychopharmacol. 2014 Dec;22(6):541-7. doi: 10.1037/a0037912. Epub 2014 Sep 15. Exp Clin Psychopharmacol. 2014. PMID: 25222546 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information